Jul 15 2026
—
—
| Reported | EPS est | EPS actual | Surprise | Revenue est | Revenue actual | Surprise |
|---|---|---|---|---|---|---|
| Jan 29 2026 | — | $0.16 | — | $65M | $63M | -3.7% |
| Oct 27 2025 | — | $0.05 | — | $64M | $64M | +0.0% |
| Jul 25 2025 | — | $0.24 | — | $68M | $65M | -4.3% |
| Apr 24 2025 | — | ($0.35) | — | $61M | $61M | -0.2% |
| Jan 16 2025 | — | $0.26 | — | $66M | $66M | +0.6% |
| Oct 10 2024 | — | $0.27 | — | $74M | $69M | -6.7% |
| Jul 10 2024 | — | $0.26 | — | $60M | $60M | +0.3% |
| Apr 10 2024 | — | $0.26 | — | $67M | $258M | +287.1% |
| Jan 16 2024 | — | $0.26 | — | $74M | $72M | -1.7% |
| Oct 12 2023 | — | $0.23 | — | $68M | $66M | -2.4% |
| Jul 12 2023 | — | $0.25 | — | $69M | $67M | -3.2% |
| Apr 12 2023 | — | $0.00 | — | $72M | $536592 | -99.3% |
No earnings transcripts available for HGYMF
Transcripts may not be available for all companies
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $38.37B | $39.06B | $41.74B | $43.33B |
| Low | $38.37B | $39.06B | $41.74B | $43.33B |
| High | $38.37B | $39.06B | $41.74B | $43.33B |
| EBITDA Avg | $4.57B | $4.13B | $3.82B | $3.60B |
| Low | $4.57B | $4.13B | $3.82B | $3.60B |
| High | $4.57B | $4.13B | $3.82B | $3.60B |
| EBIT Avg | $71M | $73M | $77M | $94M |
| Low | $71M | $73M | $77M | $94M |
| High | $71M | $73M | $77M | $94M |
| Net Income Avg | $20M | $21M | $24M | $36M |
| Low | $20M | $21M | $24M | $36M |
| High | $20M | $21M | $24M | $36M |
| EPS Avg | $0.89 | $0.95 | $1.07 | $1.59 |
| Low | $0.89 | $0.95 | $1.07 | $1.59 |
| High | $0.89 | $0.95 | $1.07 | $1.59 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |